Organisms | Evidence |
---|---|
Mus musculus (house mouse) | |
Rattus norvegicus (Norway rat) | |
Homo sapiens (human) | |
Drosophila melanogaster (fruit fly) | |
Streptococcus pneumoniae |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT1 | UDP-Gal |
|
R |
|
R | |
B3GALT5 | UDP-Gal |
|
R |
|
R |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl |
Pathway Name | Organism |
---|---|
E.coli O152 | Escherichia coli |
E.coli O156 | Escherichia coli |
E.coli O158ac | Escherichia coli |
E.coli O159 | Escherichia coli |
E.coli O160 | Escherichia coli |
E.coli O161 | Escherichia coli |
E.coli O167 | Escherichia coli |
E.coli O168 | Escherichia coli |
E.coli O16H48K12 | Escherichia coli |
E.coli O170 | Escherichia coli |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
35325595 | Facile discovery of surrogate cytokine agonists | Yen M | 2022 Apr 14 |
|
35344711 | Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody | Li C | 2022 Apr 14 |
|
35422493 | O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGgamma interaction | He X | 2022 Apr 14 |
|
35420322 | Molecular docking unveils the potential of andrographolide derivatives against COVID-19: an in silico approach | Veerasamy R | 2022 Apr 14 |
|
35247328 | Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases | Chang A | 2022 Apr 14 |
|
35419655 | Simulations suggest double sodium binding induces unexpected conformational changes in thrombin | Wu D | 2022 Apr 13 |
|
35385697 | Epithelial STAT6 O-GlcNAcylation drives a concerted anti-helminth alarmin response dependent on tuft cell hyperplasia and Gasdermin C | Zhao M | 2022 Apr 12 |
|
35414690 | The intra-mitochondrial O-GlcNAcylation system rapidly modulates OXPHOS function and ROS release in the heart | Dontaine J | 2022 Apr 12 |
|
35479087 | Inhibition of O-GlcNAcylation Decreases the Cytotoxic Function of Natural Killer Cells | Feinberg D | 2022 Apr 11 |
|
35394827 | Cryo-EM structures of the human surfactant lipid transporter ABCA3 | Xie T | 2022 Apr 08 |
|
Title | Authors | Source | Publication Date | PubMed ID |
---|---|---|---|---|
Dynamic glycosylation of the transcription factor CREB: a potential role in gene regulation. |
|
J Am Chem Soc | 2003 Jun 4 | 12769553 |
Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. |
|
Biochim Biophys Acta | 1999 Oct 18 | 10572927 |
Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. |
|
J Biol Chem | 1999 Nov 5 | 10542233 |
An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. |
|
J Biol Chem | 1999 May 21 | 10329728 |
Vertebrate lens alpha-crystallins are modified by O-linked N-acetylglucosamine. |
|
J Biol Chem | 1992 Jan 5 | 1730617 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025